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Fertility Education Needs and Disparities in Female Breast Cancer Patients 
Introduction 
Recent advances in the treatment of all types of cancer have improved the survival rate 
of cancer patients and many have the chance to resume a normal life after treatment. This is 
certainly true for women survivors of breast cancer. Although studies show that there are 
minimal effects on the offspring of cancer survivors conceived after therapy, and that a majority 
of post treatment pregnancies are unaffected by previous cancer treatment, some of the 
treatments that save patients
 
lives may have an effect on their fertility and, for women, whether 
or not they can conceive in the future.  
While the majority of breast cancer patients are older women, about five percent are 
under age forty. One in every three thousand pregnancies is complicated by breast cancer, 
either during the pregnancy or in the postpartum months (Komen Statistics, 2007). Treatment 
with chemotherapy causes direct damage to the ovaries, with some drugs affecting fertility more 
than others. During treatment, a woman may have amenorrhea temporarily or may enter early 
onset menopause. After chemotherapy, a woman may require further hormone treatment, 
during which time ovulation may or may not occur, but childbearing must be delayed until these 
treatments are complete. If early menopause occurs, fertility is lost (Thewes, et al. 2005). 
Women need to be fully informed of these side effects of treatment to prepare and make 
informed decisions about how to proceed with treatment.  
Treatment for breast cancer is particularly grueling for the patient and some health care 
providers are reluctant to advise pregnancy after treatment. The hormonal nature of some types 
of breast cancer creates a theoretical problem with pregnancy hormones and recurrence of 
breast cancer. While it was thought in the past that the increased level of hormones a woman 
experiences while pregnant could activate breast cancers that are positive for hormone 
receptors, this philosophy is currently being questioned. In fact, there have been no studies that 
show pregnancy to be detrimental in cancer survivors and, in fact, there is some evidence to 
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suggest that pregnancy may have a protective effect on the breast cancer survivor (Calhoun & 
Hansen, 2005-2006). With this knowledge, would a breast cancer survivor decide to become 
pregnant after breast cancer?  
The purpose of this study is to determine if premenopausal breast cancer patients feel 
they are well informed of the risks to their fertility and future pregnancies caused by treatment. 
The study will also explore from where patients get their information about fertility and what 
percentage of patients would like to have children after treatment. It is hypothesized that less 
than half the patients feel fully informed of their fertility options and that a majority of patients 
would like to have the option of pregnancy after treatment available to them.  
Literature Review 
A. Breast Cancer 
1. Pathophysiology 
Breast cancer strikes one in eight women in their lifetime. In 2007 approximately 
178,480 new cases of breast cancer were diagnosed in the United States alone. With breast 
cancer being the second most lethal type of cancer in women, three percent of people affected 
with breast cancer will die from it (Statistics, 2006). Breast cancer is a malignancy of the breast 
tissue, typically found in the ducts and lobules. The rate of growth and spread of malignant cells 
varies greatly from patient to patient; some develop distant metastases quickly and some take 
years for a palpable lump to form. The initial injury in breast cancer is to the DNA. There is a 
mutation, interaction or environmental agent that causes a change in the DNA. This change in 
DNA causes abnormal, uninhibited growth of the breast tissue cells (Huether & McCance, 
2004).  
Some people are at an increased risk of developing breast cancer because of inherited 
genetic alterations. The Breast Cancer-1 (BRCA-1) gene is a tumor suppressor gene and can 
inhibit tumor development when it s working correctly. If there is a mutation, tumor development 
and growth is not suppressed. Having a mutation in this gene puts a woman at a 50% to 85% 
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chance of developing breast cancer in her lifetime. The BRCA-2 gene mutation has similar 
consequences. If women are aware that they carry these genetic mutations, they may choose to 
have a prophylactic mastectomy or oophorectomy (Lewis, Heitkemper, & Dirksen, 2004).  
2. Role of Hormones in Breast Cancer 
One of the tests a woman diagnosed with breast cancer will likely undergo will be one to 
determine if her cancer is estrogen receptor positive. Estrogen receptors are protein molecules 
in cells that can become active when an estrogen molecule enters the cell. When the receptor 
and the estrogen molecule bind, estrogen responsive genes begin to make messenger RNA. 
The messenger RNA then makes proteins that guide the cell s actions. In the breast, these 
messages tell the tissue to proliferate. This increased level of proliferation increases the chance 
that a mutated cell could divide and develop into cancer. It also increases the chance that a 
normal cell could mutate while dividing, therefore creating a mutated cell (Estrogen Receptors, 
2006). 
3. Pregnancy After Breast Cancer  
Since hormones play such an important role in the development and growth of breast 
cancer, there is some concern about how pregnancy will affect a woman who was treated for 
breast cancer. There is a fear that the pregnancy hormones might cause activation of distant 
metastases. There have not been any studies to date, however, that have found pregnancy to 
be hazardous to breast cancer survivors. In fact, studies have found that those survivors who 
did get pregnant following treatment for breast cancer had an increased chance of survival. In 
this study Calhoun and Hansen (2005-2006) give two explanations for the increased survival of 
child bearing breast cancer survivors. The first reason is called the Healthy Mother Effect. This 
states that the women who feel the healthiest and have no signs of recurring cancer will be the 
women who try to, and do, get pregnant. This suggests that those women who do have children 
after treatment were the healthiest before pregnancy and hence maintain their good health 
afterward (Calhoun & Hansen, 2005-2006).  
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The second explanation the authors give to increased survival is called the fetal antigen 
hypothesis. This hypothesis states that the mother may receive protective antibodies while 
pregnant. This is based on the fact that the cells of the fetus and breast cancer cells share 
similar antigens. The antigens expressed by the fetus may activate the woman s immune 
system, stimulating cellular and humoral responses against breast cancer. This would also help 
to explain why there isn t an increased rate of cancer recurrence after exposure to high levels of 
pregnancy hormones in this population (Calhoun & Hansen, 2005-2006). 
B. Treatments 
1. Fertility 
Women diagnosed with breast cancer at a younger age often have a different clinical 
picture at the time of diagnosis. It is more likely that the cancer will be more advanced and at a 
later stage upon diagnosis (reference). In addition, the majority of younger women with breast 
cancer have tumors that are estrogen receptor negative, a prospect that limits treatment 
options. However, younger women often respond better to chemotherapy than older breast 
cancer patients, so most treatments include chemotherapy, even for early-stage tumors (Duffy, 
Allen, & Clark, 2006).  As a result of chemotherapy, temporary or permanent menopause may 
occur. The type of chemotherapy drugs used and the woman s age largely determine whether a 
woman will go through therapy-induced menopause and, if so, whether she will regain her 
menstrual cycle, and her fertility, after treatment (Minton & Munster, 2002).  
As the national average age for childbirth continues to rise, fertility becomes even more 
important for the breast cancer patient. A woman at age 30 who receives chemotherapy is 
unlikely to lose her fertility due to treatment, but at age 35 there is an 18% chance that fertility 
will be lost. At age 40, women have a 40% chance of having permanent menopause due to 
treatment. Even if the woman does regain fertility, the chance she will experience  premature 
menopause is much higher than for the general population (Brennan et al, 2005).  
2. Effect on Offspring 
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In a study by Fossa, et al (2005), the outcomes of pregnancy and perinatal health in 
offspring of cancer survivors were studied. Three databases were linked to get a sample size of 
13,817 subjects with a history of an invasive malignancy and in the age range of 15 to 45 at the 
time of diagnosis. All pregnancies that occurred nine months after diagnosis were included, 
which included 433 women who successfully had a total of 678 children after the cancer 
diagnosis. For females, the 10-year probability of post-diagnosis pregnancy was 9%, except for 
women with choriocarcinoma, who had a 50% probability of pregnancy post-diagnosis. The 
mean age for delivery of post-diagnosis children was 29.8 years for females, compared to the 
control population, in which the mean maternal age was 26.8 years. In the post-diagnosis group 
there were significantly more twins and triplets born, with the incidence of multiple births 
increasing in 1991 to 1998 (Fossa et al, 2005).   
In comparison to the control group, the female cancer patients had more caesarean 
section deliveries, even when multiple births were excluded, but this statistic has decreased 
steadily over the years of the study. This study did not find any increase in congenital 
malformations in offspring of cancer patients. While there was no increase in perinatal mortality, 
the post-diagnosis group did have more pre-term births. On average, the cancer patients 
children had a 6 day shorter gestations, which is an insignificant amount of time in a near full 
term pregnancy. The female cancer survivors children also weighed an average of 130 grams 
less at birth. This study was cross-sectional and doesn t take into account the birth weigh of 
siblings or congenital malformations diagnosed later in life. The results of this study show that 
post-diagnosis pregnancy, overall, is possible and safe for mother and baby (Fossa, et al., 
2005). Good!  
After overcoming cancer and the related treatment, do survivors still want to have 
children? In a study by Schover (2005), it was found that 60% of cancer survivors would want to 
have children even if they die prematurely. Ninety four percent reported that they felt well 
enough to have children, and 70% felt that experiencing cancer would make them a better 
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parent. The participants in this study were 43 men 83 and women from the Tumor Registry at 
the Cleveland Clinic Foundation. The criteria for the study included a diagnosis of cancer before 
age 35 and a minimum current age of 14 and all participants had to be disease free at the last 
check-up. This study did include patients with several types of cancer, so these results are not 
specific to breast cancer patients (Schover, 2005). If it is safe to conceive after cancer treatment 
and a large number of patients desire children, health care providers may need to consider a 
treatment plan that has less chance of causing loss of fertility and to more thoroughly discuss 
these topics with patients.   
C. Patient Education 
1. Educational Needs 
In a study by Duffy, Allen and Clark (2005), young women with a breast cancer 
diagnosis were questioned regarding reproductive health counseling. The study included 164 
premenopausal women under age 45 who were recruited from oncology offices and were 
beginning their first round of chemotherapy. The women were participants in a randomized 
controlled trial aimed at stress reduction. Telephone interviews were conducted in which the 
women reported what fertility topics were discussed with different doctors. The interviews were 
conducted on average 3.7 weeks after receiving their first chemotherapy treatment. The 
demographics of the women found that the majority were white, married, had children and had a 
household income of greater than $60,000. The median number of physicians consulted by the 
patients for their cancer care was four (Duffy, Allen and Clark, 2005).   
The results of the study showed that 68% of women did have a discussion with one of 
their health care providers about the possibility of early menopause as a consequence of 
treatment. However, only 34% of the participants reported that they had a discussion with their 
health care provider about fertility, even thought all the women were premenopausal. For those 
that did, these discussions were most often with the medical oncologist. The odds of recalling a 
fertility and menopause discussion were greatly increased in those women who were privately 
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insured and in those women receiving hormone treatment for their cancer. Odds of recalling 
discussions were much lower in the lower income group. The two factors that were most 
influential on whether or not a fertility discussion took place were having less than four 
physicians and women who already had children. Higher anxiety levels were also associated 
with decreased odds of recalling a fertility discussion. It may be women with higher anxiety have 
trouble remembering these discussions or it may be that the health care provider avoided 
having this discussion with an anxious patient (Duffy, Allen & Clark, 2005). Regardless, in a 
population of women that are premenopausal, a discussion about fertility and menopause would 
be an important part of patient education. The health care provider should take the time to 
ensure that the patient understands the side effects and is aware of what may happen to her 
body.  
In a qualitative study by Thewes, Meiser, Rickard and Friedlander (2003) 24 women 
under age 45 at diagnosis discussed their information needs and experiences related to their 
breast cancer diagnosis. The women were broken into four focus groups and were also 
contacted by telephone for further interview. Transcripts of the focus groups were analyzed for 
common themes. Of the 24 women that participated, three had treatment induced menopause 
and eleven of the women had a temporary cease in menstruation. Some of the women 
described fertility as the major concern at the time of diagnosis, while others were caught up in 
the decisions about treatment and the shock of the diagnosis. Many of the women agreed that 
as the treatment continued, fertility became more of a concern. Those women who did go 
through menopause said that information related to menopause was important to them, even if 
they were not interested in further childbearing (Thewes, Meiser, Rickard & Friedlander, 2003).  
Several of the women in the focus groups reported they had not received adequate 
information about their fertility. They felt the information came too late, if at all. Many women 
reported that the burden of finding information related to menopause and fertility was in their 
hands. Many of the women didn t even know at the time of the focus groups what their fertility 
                                                                                                 Fertility and Breast Cancer     9 
status was. One woman said that there is a reluctance of the doctors to realize that this is a 
really important issue. They have their priorities in curing you but they just thought it wasn t that 
important (p. 504). A number of the women stated that they did their own research on the 
topics of fertility and menopause. They talked with other patients, consulted books, magazines, 
support groups and the internet to learn more. Since this was a small, qualitative study, the 
opinions and feelings of these women may not be similar to the larger population of young 
breast cancer patients. Larger scale studies need to be done with a wider variety of breast 
cancer survivors (Thewes, Meiser, Rickard &Friedlander, 2003). This study is evidence to the 
fact that women want more information early in the diagnosis. Since it is such an overwhelming 
time, there should be multiple discussions and resources given to the women if she seeks 
further information.   
The results of these studies show that breast cancer patients do want more information 
about menopause and fertility during treatment. Many of these women felt under-prepared for 
the effects that chemotherapy had on their fertility. Several studies show that it is safe for breast 
cancer survivors to have children after treatment and may even have protective effects on the 
mother. If the woman is less than thirty-five there is a very good chance that she won t stop 
menstruating during treatment, and if she does, it will most likely return after treatment. Certain 
chemotherapy drugs are less toxic to the ovaries than others, and there are also other 
treatments available to preserve ovarian function. Ensuring that women are aware of these facts 
is likely to improve their ability to cope with the outcomes of therapy.  
With all the information about fertility and menopause available, health care providers 
need to know what information to tell their patient, but many questions still remain. How would 
women prefer to receive this information?  Would they like to have a discussion with their 
oncologist and receive handouts, or would they prefer to see a fertility specialist concerning 
these issues? Are patients getting a large amount of information from sources other than their 
doctors? Are these reliable sources? And what are the women s feelings about having children 
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after treatment? Is childbearing still a value of theirs or are they more concerned with improving 
their health and dealing with the cancer diagnosis? This research hopes to find answers to 
some of these questions for a better understanding of the educational needs of our patients.    
Methods 
A. Sample 
The sample population for this study included women ages eighteen to fifty who reported 
a breast cancer diagnosis in the past ten years. Since women older than fifty years old are likely 
to be in natural menopause, and thus likely to have received less information regarding fertility 
and menopause changes with breast cancer treatment, were excluded from this study. In 
addition, since very few women under age eighteen are diagnosed with breast cancer, they also 
were excluded from the study. A survey developed to address the research questions listed 
above was developed by the investigator, and was placed on the Complementary Alternatives 
for Breast Cancer Survivors website. Thus, only women with access to a computer with internet 
access were able to complete the survey. Participants were recruited from multiple sources 
including: the Columbus Chapter of Susan G. Komen Foundation database of breast cancer 
patients, distribution of fliers at two Komen Columbus events, Komen Columbus volunteers who 
were asked to spread the word about the survey, notice of the survey on the Young Breast 
Cancer Survivor Coalition website, and anyone who happened to visit the website could fill out 
the survey.  
B. Procedure 
The student researcher will include the survey questions in a larger survey being done 
by faculty at the Ohio State University College of Nursing. The patient database from the Susan 
G. Komen Foundation of Columbus was used to recruit participants as well as word of mouth 
and survey notices on other breast cancer support sites, such as the Young Breast Cancer 
Survivor Coalition. The survey was located on the internet at the Complementary Alternatives 
for Breast Cancer Survivors website. This website contains links and information on alternative 
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and complementary therapies, symptom management, and survivors and co-survivors as well 
as the survey. Women were told the inclusion and exclusion criteria and the time commitment 
for completing the questionnaires. The participants were asked to answer questions regarding 
demographics, as well as a reproductive questionnaire and a knowledge survey. The 
participants also had the opportunity to sign up on a separate database to enter drawings for 
gifts and gift certificates ranging from $5 to $50 in value. During the data collection process, 
drawings for $5 to $25 prizes were held every two weeks and $50 gift certificates will be given 
out at the end of data collection. Those survey participants that were listed as recruiters by other 
survey participants were entered into a drawing for a $50 gift certificate.  
C. Data Analysis  
Descriptive statistics were compiled to describe the sample population. Satisfaction with 
education by the health care provider was evaluated and compared based on pregnancies, 
education and other demographic information. The knowledge survey was scored by number of 
correct answers. Women with and without children since diagnosis were compared based on 
demographic and knowledge variables. The student s t-test was also used to evaluate the 
differences between groups.  
Results  
A. Participation and Demographics  
The survey was completed by 17 women between the ages of 33 and 53 years old. The 
mean age was 44.6 years old. 68.8% of the women were currently married and 31.2% were not 
married. 37.5% of the women had a graduate or professional degree. 31.2% had a college 
degree. 12.5% had some college education. 6.2% completed high school and 12.5% had less 
than a high school degree. Half of our participants had children at the time of the survey and all 
of these children were born before their breast cancer treatment. Breast cancer diagnosis 
occurred before age 40 in 63% of the women.  
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B. Findings 
None of the women surveyed were asked to meet with a fertility specialist at any time 
throughout their treatment. 25% of the women received their fertility and menopause education 
information from a non-professional source, such as the internet or support groups. A significant 
percentage of the women reported dissatisfaction with the fertility and menopause education 
they received after their diagnosis (See Table 1).  
Table 1.
   
Very true  Somewhat True Somewhat not true Not true 
Overall, I was satisfied with my 
fertility/menopause education 
25% 31.2% 18.8% 25% 
I had to search for information 
relating to fertility/menopause 
18.8% 25% 12.5% 43.8% 
I felt I received information at 
the right time 
37.5% 12.5% 18.8% 31.2% 
I wanted more information about 
fertility/menopause 
18.8% 25% 18.8% 25% 
The research found a positive correlation between women who said they would have like 
to receive more information and those women who had to ask for more information (Pearson r = 
.572, p = .02). For those people who had a strong desire to have children, they desired 
significantly more information relating to fertility and menopause (T= -2.93, df = 10, p = .015). 
There was a positive correlation with overall satisfaction in education received and how well 
informed the women felt (Pearson s r = .728, p < .001). There was a positive correlation 
between total quiz score and education attainment. The average quiz score for those women 
with a high school education or less was 2.8 ± .73 out of 6.  The average quiz score for those 
women with more than a high school education was 3.36 ±.54 out of 6.  
D. Discussion 
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This research study highlights the needs of female breast cancer patients that are not 
being met. The majority of women surveyed were not completely satisfied with the education 
they received concerning fertility and menopause. Women who have completed a high school 
education or less were found to have lower quiz scores. This population, in particular, should be 
evaluated for response to and understanding of education given. Those women who had a 
strong desire to have children after treatment desired significantly more information relating to 
fertility and menopause. Female breast cancer patients should be asked about their desire to 
have children before the treatment process begins. This would assist the healthcare provider in 
understanding the woman s needs relating to fertility education as well as the need to meet with 
a fertility specialist.  All premenopausal women should be offered the opportunity to meet with a 
fertility specialist to obtain a more thorough explanation of what may happen to their fertility 
status as a result of treatment as well as learn about fertility options, if interested. This 
education will assist female breast cancer patients to anticipate and be knowledgeable about 
what may happen to their fertility.   
Throughout patient education, the nurse or other educator should evaluate the patient 
for the amount of education desired. Some women may want to know quite a bit about fertility 
and menopause, while other women may not be concerned with these topics. Nurses should 
also take the opportunity to act as patient advocates and bring the issues of fertility and 
menopause up with female breast cancer patients before their treatment. Patients should be 
fully aware of the effects that treatment can have on their fertility and menopause as well as the 
options available to them. Nurses have a responsibility to their patients to provide this education 
and ensure that patients comprehend the effects of treatment. 
E. Conclusion 
The results of this study clearly show the need for improved education of female breast 
cancer patients, specifically education on fertility and menopause. Nurses have a unique 
opportunity to act as patient advocates and encourage female breast cancer patients to seek 
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out information in this area. Assisting these women in finding credible and accessible 
information is one way in which nurses can provide quality education to their patients. This 
education can be essential for women when they are returning to a more normal life after 
treatment concludes.   
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